肝细胞癌
经皮
体内
医学
阿霉素
化疗
癌症
癌症研究
光动力疗法
肿瘤科
外科
内科学
生物
化学
生物技术
有机化学
作者
Jun Hu,Wenrui Wu,Yufei Qin,Chao Liu,Peng Wei,Jing Hu,Peter H. Seeberger,Jian Yin
标识
DOI:10.1002/adfm.201910084
摘要
Abstract Hepatocellular carcinoma (HCC) causes high morbidity and mortality due to a lack of adequate treatments. Cancer treatments have benefited from nanotechnology approaches that integrate multimodal synergistic therapies. A synergistic, minimally invasive strategy of interventional photodynamic therapy (IPDT) and chemotherapy for HCC treatment through percutaneous transperitoneal puncture is disclosed that is based on photosensitive porphyrinic galactose‐modified metal‐organic frameworks (PCN‐224) first used as hepatic targeting and encapsulated with anticancer drug doxorubicin (DOX@Gal‐PCN‐224). Real‐time imaging reveals the effective accumulation of the integrated nanosystem in the HCC cells and tumor tissues due to hepatic targeting. Evaluation of the anti‐tumor efficiency of this nanosystem on orthotopic transplantation tumors with the aid of minimally invasive intervention shows a tumor inhibition rate of 98%. The synergistic effects induce high‐level cell apoptosis and tissue necrosis in vitro and in vivo. This bimodal IPDT/chemotherapy strategy holds great potential in the clinical treatment for HCC.
科研通智能强力驱动
Strongly Powered by AbleSci AI